Shares of Ocugen (NASDAQ: OCGN) were sinking 4.8% lower as of 11 a.m. ET on Tuesday after falling as much as 7.1% earlier in the day. Instead, today's decline appears to be due to short-term profit-taking after Ocugen jumped late last week after a positive regulatory development in India for COVID-19 vaccine Covaxin.